No Relationship between Osteocalcin and the Microvascular Complications of Type 2 Diabetes

Basit Öğe Kaydı
dc.authoridISIK, SERHAT/0000-0002-3477-5889;
dc.contributor.authorKucukler, Ferit Kerim
dc.contributor.authorBardak, Simge
dc.contributor.authorCelik, Tugrul
dc.contributor.authorTutuncu, Yasemin
dc.contributor.authorAkbaba, Gulhan
dc.contributor.authorIsik, Serhat
dc.contributor.authorKaraahmetoglu, Selma
dc.date.accessioned2025-10-24T18:09:59Z
dc.date.available2025-10-24T18:09:59Z
dc.date.issued2014
dc.departmentMalatya Turgut Özal Üniversitesi
dc.description.abstractPurpose: Osteocalcin, one of the osteoblast-specific proteins is produced and secreted by osteoblasts. Although osteocalcin has been thought to play a role only in bone formation, recent studies have shown that it also enhances insulin sensitivity and insulin secretion from pancreatic beta cells. Several studies have reported lower serum osteocalcin levels in patients with type 2 diabetes mellitus (T2DM) than in non-diabetic individuals; and a negative correlation between microvascular complications and osteocalcin levels in type 1 diabetes mellitus (T1DM) patients. We investigated the relationship between microvascular complications and serum undercarboxylated osteocalcin (uOC) levels in T2DM patients. Material and Method: One hundred seventy-nine patients with T2DM aged between 30 and 60 years were randomly included in the study; 101 patients with microvascular complications formed the patient group, and the other 78 without a microvascular complication formed the control group. The patients were evaluated for diabetic nephropathy, retinopathy and neuropathy. The ELISA method was used to measure uOC levels. Results: The two groups were statistically similar with regard to age, gender and body mass index (BMI). Duration of diabetes was shorter in control group than in patient group (p<0.05). HbA1c level in patient group was significantly higher than in controls (p<0.05). There was no statistically significant difference in uOC levels between the groups (p>0.05). Discussion: There was no relationship between serum osteocalcin levels and the microvascular complications of T2DM.
dc.identifier.doi10.4274/tjem.2745
dc.identifier.endpage131
dc.identifier.issn1301-2193
dc.identifier.issue4
dc.identifier.scopus2-s2.0-84916237325
dc.identifier.scopusqualityQ4
dc.identifier.startpage126
dc.identifier.urihttps://doi.org/10.4274/tjem.2745
dc.identifier.urihttps://hdl.handle.net/20.500.12899/3921
dc.identifier.volume18
dc.identifier.wosWOS:000217373800006
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherGalenos Yayincilik
dc.relation.ispartofTurkish Journal Of Endocrinology And Metabolism
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20251023
dc.subjectType 2 Diabetes Mellitus; undercarboxylated osteocalcin; microvascular complications
dc.titleNo Relationship between Osteocalcin and the Microvascular Complications of Type 2 Diabetes
dc.title.alternativeTip 2 diyabetin mikrovasküler komplikasyonları ile osteokalsin arasında İlişki var mı?
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu